All India Institute of Medical Sciences (AIIMS) Delhi has started clinical trials of Bharat BioTech’s indigenous Covid-19 vaccine COVAXIN on humans from today.
Breaking-AIIMS in Delhi begins Phase-3 trials of COVAXIN from today
All India Institute of Medical Sciences (AIIMS) Delhi has started clinical trials of Bharat BioTech’s indigenous Covid-19 vaccine COVAXIN on humans from today.